ArticleBreast cancer research and treatment2022

Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer.

Lili Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.